Gradient AI Launches Sentinel to Predict High-Cost Health Conditions Using Lab Data
By Lauren Towner · 19 November 2026
In brief: Gradient AI has launched Sentinel, an AI tool that analyzes lab results to identify high-cost health conditions before they enter the claims process, enabling more accurate underwriting.
| Product Name | Sentinel |
|---|---|
| Core Platform | SAIL™ |
| Data Source | Lab results and millions of medical records |
| Target Users | Underwriters, Carriers, MGAs, and TPAs |

Gradient AI has launched Sentinel, a tool designed to identify high-cost medical conditions by analyzing lab results before they reach the claims stage. For group health underwriters and stop-loss carriers, this provides a critical head start in risk assessment, allowing for more precise pricing and improved medical loss ratios by closing the data lag between diagnosis and billing.
What was announced
Sentinel is an AI-driven solution that targets a specific pain point in group health underwriting: the time gap between a patient’s initial diagnosis and the appearance of that condition on a medical or pharmacy claim. By mining lab results—which are often the first recorded data point in a member’s healthcare journey—the tool provides underwriters with early indicators of potentially expensive conditions. This allows for risk quantification well before traditional medical or pharmacy claims data is available, diminishing the likelihood of pricing policies based on incomplete information.
The tool is offered as an integrated add-on to SAIL™, Gradient AI’s flagship group health underwriting and stop-loss platform. SAIL™ is trained on millions of medical records and health data points, using medical and prescription patterns to uncover hidden comorbidities and severity trends. Sentinel layers its lab-based intelligence onto this existing framework, using the same census data that SAIL™ already utilizes. This integration is designed to provide a more comprehensive risk profile without the operational friction of onboarding a new software system. The primary objectives of the tool include enabling more accurate pricing strategies, facilitating faster quote turnaround times, and supporting straight-through processing and reserve optimization for insurance providers.
"By swimming further upstream into lab stages, Sentinel presents critical member information at the earliest possible timeframe. From there, that insight combines with the medical, pharmacy, and other claims data offered through our existing SAIL™ ecosystem to provide a more robust risk picture. The immediate, tangible results include more accurate rate-setting and improved Medical Loss Ratio performance."
Marc Jeffreys Health GM, Health Gradient AI
The companies involved
Gradient AI is an enterprise software provider specializing in artificial intelligence solutions tailored for the insurance industry. The company focuses on delivering decision intelligence to global insurance carriers, MGAs, and third-party administrators, particularly within the health and benefits space. Its core platform, SAIL™, is positioned as a central ecosystem for group health underwriting and stop-loss risk management, aiming to replace manual processes with data-driven automation.
The firm has established itself as a significant player in the insurtech market, recently undergoing a brand refresh to better reflect its scale and focus on decision intelligence. Gradient AI’s growth has been supported by external capital, including funding from CIBC Innovation Banking, which has enabled the company to expand its product suite and integration capabilities. Beyond its proprietary technology, the company engages in strategic partnerships, such as its collaboration with Connexure, to streamline risk management workflows and enhance the connectivity between carriers and MGUs. This positioning allows Gradient AI to act as a bridge between complex medical data and actionable underwriting insights.
What FF News has reported before
FF News has followed Gradient AI’s expansion through 11 separate reports, previously covering the company’s brand refresh aimed at scaling its decision intelligence for global carriers. The publication also covered a major upgrade to its renewal analytics, which introduced new risk scoring and peer benchmarking capabilities for group health. Furthermore, FF News noted the company’s financial growth following capital investment from CIBC Innovation Banking and its efforts to streamline workflows through a partnership with Connexure.
What this means from an insurtech perspective
This announcement highlights a significant shift in the health underwriting value chain from retrospective analysis to proactive risk identification. By moving "upstream" to lab data, Gradient AI is addressing the inherent weakness of pharmacy and medical claims, which often carry a 30-to-90-day reporting lag. For carriers and MGAs, this reduces the "blind spot" during the quoting process, directly impacting medical loss ratios by preventing the underpricing of high-risk groups. This puts pressure on incumbent vendors who rely solely on historical claims data. The ability to integrate this without a new system rollout also addresses the industry’s ongoing struggle with legacy core-system modernization and operational friction.
Frequently asked questions
How does Gradient AI Sentinel identify high-cost claimants?
Sentinel identifies high-cost claimants by mining insights from lab results, which are often the first data points in a patient's journey. By analyzing these early signals before they appear in medical or pharmacy claims, the tool provides underwriters with an earlier indication of potential risk.
What is the benefit of using lab data in insurance underwriting?
Using lab data allows underwriters to virtually eliminate the lag period between a condition's onset and its appearance in claims. This leads to more accurate rate-setting, improved Medical Loss Ratio (MLR) performance, and the ability to price groups based on complete, real-time information.
Does Sentinel require a new system implementation?
No, Sentinel does not require a new system implementation. It is offered as an add-on to Gradient AI’s existing SAIL™ ecosystem and uses the same census data, ensuring negligible ramp-up time and no learning curve for current users.
About the companies
Companies in this story: Gradient AI
People in this story: Marc Jeffreys